Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylamide SCHEMBL5161693 | 1.00 | ALDH1A1 (0.55) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| Acrylamide SCHEMBL9228749 | 0.97 | ALDH1A1 (0.58) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| Acrylamide SCHEMBL9228743 | 0.97 | ALDH1A1 (0.58) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| Acrylic Acid SCHEMBL28326098 | 0.85 | LMNA (0.50) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| Ethylene SCHEMBL11567182 | 0.84 | — | — | |
| Acrylamide SCHEMBL9304706 | 0.84 | ALDH1A1 (0.79) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| Acrylamide SCHEMBL35469 | 0.84 | ALDH1A1 (0.79) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| SCHEMBL9673 | 0.84 | — | — | |
| Acrylamide SCHEMBL679118 | 0.84 | ALDH1A1 (0.79) | ALDH1A1TSHRFGFR4TDP1LMNA | |
| SCHEMBL5214305 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1758637-A1 | WOUND DRESSINGS FOR VACUUM THERAPY | Ethicon, Inc. (US) | 2007-03-07 | — | — | EP | disclosed |
| EP-1635884-A1 | HYDROGEL COMPOSITIONS COMPRISING ENZYMES | Johnson & Johnson Medical Ltd. (GB) | 2006-03-22 | — | — | EP | disclosed |
| WO-2005123170-A1 | WOUND DRESSINGS FOR VACUUM THERAPY | ETHICON, INC. (US) | 2005-12-29 | — | — | WO | disclosed |
| WO-2004112851-A1 | HYDROGEL COMPOSITIONS COMPRISING ENZYMES | JOHNSON & JOHNSON MEDICAL LIMITED (GB) | 2004-12-29 | — | — | WO | disclosed |
| EP-1429702-A1 | THERAPEUTIC WOUND DRESSINGS WITH EXUDATE-DEPENDENT ENLARGEMENT OF APERTURES | Johnson & Johnson Medical Ltd. (GB) | 2004-06-23 | — | — | EP | disclosed |
| EP-1409030-A1 | APERTURED SHEET MATERIALS CONSISTING OF A HYDROGEL COMPOSITIION | Johson & Johson Medical Limited (GB) | 2004-04-21 | — | — | EP | disclosed |
| WO-2004024196-A1 | WOUND DRESSINGS FOR THE TREATMENT OF WOUND INFECTION | JOHNSON & JOHNSON MEDICAL LIMITED (GB) | 2004-03-25 | — | — | WO | disclosed |
| WO-2003026544-A1 | THERAPEUTIC WOUND DRESSINGS WITH EXUDATE-DEPENDENT ENLARGEMENT OF APERTURES | JOHNSON & JOHNSON MEDICAL LIMITED (GB) | 2003-04-03 | — | — | WO | disclosed |
| WO-2003011352-A1 | APERTURED SHEET MATERIALS CONSISTING OF A HYDROGEL COMPOSITION | JOHSON & JOHSON MEDICAL LIMITED (GB) | 2003-02-13 | — | — | WO | disclosed |